Director of Strategic Initiatives
Co-Founder of Wonder Research
Joined Wonder Sciences as one of five initial employees.
Started as a legal & regulatory coordinator, eventually becoming Director of Strategic Initiatives.
Conceptualized the Wonder Sciences ecosystem - creating a positive feedback loop between current telemedicine protocols, data analytics, and development of future treatment offerings.
Led a team of scientific researchers and clinicians in building a treatment pipeline for psychiatric indications.
Created proposals for preclinical studies on novel formulations and observational studies on generics.
Developed procedures for new psychiatric interventions, including therapeutic integration protocols.
Oversaw the drafting and final product – investor documents, data room, strategic update decks.
Conducted industry research and analysis – entheogenic (psychedelic) medicine and telemedicine psychotherapy.
Drafted and filed patents on novel formulations and methods of use – modulation of different neurotransmitter receptor networks, therapeutic modules, diagnostics, etc.
Executed partnerships and vendor agreements with manufacturers and research organizations.
Created diagnostic and analytical frameworks incorporating psychometric and biometric data.